Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,371 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Ancestral SARS-CoV-2-specific T cells cross-recognize the Omicron variant.
Gao Y, Cai C, Grifoni A, Müller TR, Niessl J, Olofsson A, Humbert M, Hansson L, Österborg A, Bergman P, Chen P, Olsson A, Sandberg JK, Weiskopf D, Price DA, Ljunggren HG, Karlsson AC, Sette A, Aleman S, Buggert M. Gao Y, et al. Among authors: humbert m. Nat Med. 2022 Mar;28(3):472-476. doi: 10.1038/s41591-022-01700-x. Epub 2022 Jan 14. Nat Med. 2022. PMID: 35042228 Free PMC article.
The known unknowns of T cell immunity to COVID-19.
Karlsson AC, Humbert M, Buggert M. Karlsson AC, et al. Among authors: humbert m. Sci Immunol. 2020 Nov 18;5(53):eabe8063. doi: 10.1126/sciimmunol.abe8063. Sci Immunol. 2020. PMID: 33208380
Functional SARS-CoV-2 cross-reactive CD4+ T cells established in early childhood decline with age.
Humbert M, Olofsson A, Wullimann D, Niessl J, Hodcroft EB, Cai C, Gao Y, Sohlberg E, Dyrdak R, Mikaeloff F, Neogi U, Albert J, Malmberg KJ, Lund-Johansen F, Aleman S, Björkhem-Bergman L, Jenmalm MC, Ljunggren HG, Buggert M, Karlsson AC. Humbert M, et al. Proc Natl Acad Sci U S A. 2023 Mar 21;120(12):e2220320120. doi: 10.1073/pnas.2220320120. Epub 2023 Mar 14. Proc Natl Acad Sci U S A. 2023. PMID: 36917669 Free PMC article.
Restoring tumor immunogenicity with dendritic cell reprogramming.
Zimmermannova O, Ferreira AG, Ascic E, Velasco Santiago M, Kurochkin I, Hansen M, Met Ö, Caiado I, Shapiro IE, Michaux J, Humbert M, Soto-Cabrera D, Benonisson H, Silvério-Alves R, Gomez-Jimenez D, Bernardo C, Bauden M, Andersson R, Höglund M, Miharada K, Nakamura Y, Hugues S, Greiff L, Lindstedt M, Rosa FF, Pires CF, Bassani-Sternberg M, Svane IM, Pereira CF. Zimmermannova O, et al. Among authors: humbert m. Sci Immunol. 2023 Jul 14;8(85):eadd4817. doi: 10.1126/sciimmunol.add4817. Epub 2023 Jul 7. Sci Immunol. 2023. PMID: 37418548 Free PMC article.
Characteristics and outcomes of gemcitabine-associated pulmonary hypertension.
Mouillot P, Favrolt N, Khouri C, Grandvuillemin A, Chaumais MC, Schenesse D, Seferian A, Jais X, Savale L, Beltramo G, Sitbon O, Cracowski JL, Humbert M, Georges M, Bonniaud P, Montani D. Mouillot P, et al. Among authors: humbert m. ERJ Open Res. 2024 May 20;10(3):00654-2023. doi: 10.1183/23120541.00654-2023. eCollection 2024 May. ERJ Open Res. 2024. PMID: 38770007 Free PMC article.
Percutaneous atrial septal defect closure in patients with pulmonary arterial hypertension.
Valdeolmillos E, Foray C, Albenque G, Batteux C, Petit J, Lecerf F, Jaïs X, Sitbon O, Montani D, Savale L, Humbert M, Hascoët S. Valdeolmillos E, et al. Among authors: humbert m. Eur Respir J. 2024 May 30;63(5):2301649. doi: 10.1183/13993003.01649-2023. Print 2024 May. Eur Respir J. 2024. PMID: 38754963 No abstract available.
Dietary intake and glutamine-serine metabolism control pathologic vascular stiffness.
Rachedi NS, Tang Y, Tai YY, Zhao J, Chauvet C, Grynblat J, Akoumia KKF, Estephan L, Torrino S, Sbai C, Ait-Mouffok A, Latoche JD, Al Aaraj Y, Brau F, Abélanet S, Clavel S, Zhang Y, Guillermier C, Kumar NVG, Tavakoli S, Mercier O, Risbano MG, Yao ZK, Yang G, Ouerfelli O, Lewis JS, Montani D, Humbert M, Steinhauser ML, Anderson CJ, Oldham WM, Perros F, Bertero T, Chan SY. Rachedi NS, et al. Among authors: humbert m. Cell Metab. 2024 Apr 24:S1550-4131(24)00130-X. doi: 10.1016/j.cmet.2024.04.010. Online ahead of print. Cell Metab. 2024. PMID: 38701775
Characteristics and outcomes of patients developing pulmonary hypertension associated with proteasome inhibitors.
Grynblat J, Khouri C, Hlavaty A, Jais X, Savale L, Chaumais MC, Kularatne M, Jevnikar M, Boucly A, Antigny F, Perros F, Simonneau G, Sitbon O, Humbert M, Montani D; French PH Network PULMOTENSION investigators. Grynblat J, et al. Among authors: humbert m. Eur Respir J. 2024 May 2:2302158. doi: 10.1183/13993003.02158-2023. Online ahead of print. Eur Respir J. 2024. PMID: 38697649
Risk stratification refinements with inclusion of haemodynamic variables at follow-up in patients with pulmonary arterial hypertension.
Boucly A, Beurnier A, Turquier S, Jevnikar M, de Groote P, Chaouat A, Cheron C, Jaïs X, Picard F, Prévot G, Roche A, Solinas S, Cottin V, Bauer F, Montani D, Humbert M, Savale L, Sitbon O; PulmoTension Network. Boucly A, et al. Among authors: humbert m. Eur Respir J. 2024 Apr 25:2400197. doi: 10.1183/13993003.00197-2024. Online ahead of print. Eur Respir J. 2024. PMID: 38663975
1,371 results